Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.7.0.1
Consolidated Statement of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Statement of Cash Flows [Abstract]    
Cash, cash equivalents and restricted cash $ 91,238,000 $ 76,840,000
Net income (loss) 8,463,000 20,681,000
Adjustments to reconcile net income to cash provided by operating activities:    
Amortization and depreciation 6,899,000 5,772,000
Impairment of IPR&D assets 0  
Provision for losses on accounts receivable 87,000 0
Amortization of investment premiums, net 47,000 149,000
Stock-based compensation 5,474,000 5,109,000
Deferred income taxes 155,000 233,000
Gain on disposal of property and equipment (88,000) 0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 0 86,000
(Gain) loss on foreign currency (216,000) 124,000
Excess tax benefits on stock-based awards (914,000) (1,565,000)
Changes in operating assets and liabilities:    
Accounts receivable (7,436,000) 1,359,000
Inventory (5,102,000) 3,022,000
Prepaid expenses and other assets 825,000 (2,416,000)
Accounts payable, accrued expenses and other current liabilities 7,952,000 3,080,000
Accrued compensation 382,000 3,231,000
Deferred revenue and deferred profit (307,000) 2,457,000
Accrued price protection liability 6,771,000 (1,583,000)
Other long-term liabilities (320,000) (785,000)
Net cash provided by operating activities 22,672,000 38,954,000
Investing Activities    
Purchases of property and equipment (743,000) (3,222,000)
Purchases of intangible assets (120,000) 0
Purchases of available-for-sale securities (30,577,000) (37,773,000)
Maturities of available-for-sale securities 20,785,000 10,300,000
Net cash used in investing activities (10,655,000) (30,695,000)
Financing Activities    
Repurchases of common stock (334,000) (3,000)
Net proceeds from issuance of common stock 361,000 1,727,000
Minimum tax withholding paid on behalf of employees for restricted stock units (4,903,000) (1,092,000)
Net cash provided by (used in) financing activities (4,876,000) 632,000
Effect of exchange rate changes on cash and cash equivalents 1,201,000 (7,000)
Increase in cash, cash equivalents and restricted cash 8,342,000 8,884,000
Cash, cash equivalents and restricted cash at beginning of period 81,086,000 67,956,000
Cash, cash equivalents and restricted cash at end of period 89,121,000  
Supplemental disclosures of cash flow information:    
Cash paid for income taxes 421,000 30,000
Issuance of restricted stock units to Physpeed continuing employees 861,000 0
Issuance of accrued share-based bonus plan $ 3,314,000 $ 0